Welcome/ Keynote Introduction - Steve Mattarollo
The renaissance of antineoplastic immunity from stress response - Yuting Ma
A blood dendritic cell vaccine expands anti-tumour T cell responses in AML - Christian Bryant
Co-chair: Fernando Guimaraes
IL23 secretion from IEC to improve intestinal barrier integrity in IBD - Ran Wang
Multiple luminal factors impair epithelial barrier functiona nd activate colonic - Patrick Hughes
Differential immune responses between animals that clear Group B Streptococcal genital infection and those that remain colonised - Alison Carey
Macrophage depletion affects placental labyrinth vascularisation independent of fetal alloantigens - Holly Groome
Novel CD8+ T-cell targets for protection of Indigenous Australians against severe influenza disease - Luca Hensen
Distinct characteristics of the RP105-agonistic mycobacterial 19 kDa lipoprotein and RP105-mediated macrophage activation - Thomas E Schultz
Integrative analysis of miRNA and mRNA response to human malaria infection using systems immunology - Martha Cooper
Histone deacetylase 7 is an essential component of macrophage-mediated host defence, promoting phagocytosis, reactive oxygen species production and bacterial clearance - Kaustav Das Gupta
The underlying mechanisms during acute viral bronchititis in infants/pre-school children - Anya Jones
Chlorinated Flame retardant exacerbates airway inflammation through type 2 immune response - Pengcheng Zhou
Pneumovirus infection induces necroptosis in human bronchial epithelial cells and in a pre-clinical model of bronchiotis - Jennifer Simpson
NOD1 sensing of Helicobacter pylori infection mediates processing of pro-interleukin-18 in gastric epithelial cells to maintain tissue homeostasis - Le Son Tran
Age-related decline in primary CD8 T cell responses is associated with the development of senescence in virtual memory CD8 T cells - Kylie M Quinn
Innate lymphoid cell response to BCG vaccination in mice - Joanna R Kirman
IL-15 dependent melanoma-resident CD8+ T cell numbers predict patient survival and outcome of anti-PD1 therapy - Mainthan Palendira
Therapeutic implication of Programmed cell death-1 ligand 2 (PD-L2) against Melanoma - Rebecca Faleiro